EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current Status of Targeted Therapy for Biliary Tract Cancer in the Era of Precision Medicine

Takafumi Mie iD, Takashi Sasaki iD, Takeshi Okamoto iD, Takaaki Furukawa, Tsuyoshi Takeda iD, Akiyoshi Kasuga iD, Masato Ozaka, Naoki Sasahira

Cancers · 22.02.2024 · 16 (5) · 879

DOI: 10.3390/cancers16050879 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 22.02.2024. Verfasst von Takafumi Mie und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

First-line chemotherapy has been established for advanced biliary tract cancer (BTC). However, few treatment options are available as second-line treatment. Advances in comprehensive genomic analysis revealed that nearly half of patients with BTC harbor targetable genetic alterations such as fibroblast growth factor receptor (FGFR), isocitrate dehydrogenase (IDH), BRAF, human epidermal growth factor receptor 2 (HER2), microsatellite instability (MSI)-high, neurotrophic tropomyosin receptor kinase (NTRK), rearranged during transfection (RET), and poly (adenosine diphosphate-ribose) polymerase (PARP). This review summarizes currently available options in precision medicine and clinical trials for patients with advanced BTC.

Schlagwörter

Stichwörter der Autor:innen

biliary tract cancercholangiocarcinomaprecision medicinetargeted therapy

Autor:innen und Institutionen

  • Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.

ORCID-Profile: Takafumi Mie, Takashi Sasaki, Takeshi Okamoto, Tsuyoshi Takeda, Akiyoshi Kasuga

Zitieren

APA

Mie, T., Sasaki, T., Okamoto, T., Furukawa, T., Takeda, T., Kasuga, A., Ozaka, M., & Sasahira, N. (2024). Current Status of Targeted Therapy for Biliary Tract Cancer in the Era of Precision Medicine. Cancers, 16(5), 879. https://doi.org/10.3390/cancers16050879

Vancouver

Mie T, Sasaki T, Okamoto T, Furukawa T, Takeda T, Kasuga A, et al. Current Status of Targeted Therapy for Biliary Tract Cancer in the Era of Precision Medicine. Cancers. 2024;16(5):879. doi:10.3390/cancers16050879

BibTeX
@article{Mie2024,
  author = {Mie, Takafumi and Sasaki, Takashi and Okamoto, Takeshi and Furukawa, Takaaki and Takeda, Tsuyoshi and Kasuga, Akiyoshi and Ozaka, Masato and Sasahira, Naoki},
  title = {Current Status of Targeted Therapy for Biliary Tract Cancer in the Era of Precision Medicine},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {5},
  pages = {879},
  doi = {10.3390/cancers16050879}
}
Kostenlos starten →